Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Cisplatin 6Carboplatin 3spartalizumab 2Paclitaxel 2Drug Therapy 2Bevacizumab 2pembrolizumab 1netupitant, palosentron drug combination 1lenvatinib 1cyclopropapyrroloindole 1camrelizumab 1Vaccines, Synthetic 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Metronidazole 1Injections 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Docetaxel 1Dexamethasone 1Control Groups 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Uterine Cervical Neoplasms × Metronidazole × Clear all
NCT01937650 2013-09-09

Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda

Makerere University

Phase 2/3 Completed
38 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡